Clotrimazole

CHEMBL104 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
344.8 g/mol
LogP
5.0
Phase
4

A broad-spectrum azole antifungal that disrupts fungal cell membranes by inhibiting ergosterol synthesis, used to treat athlete's foot, vaginal yeast infections, and oral thrush. It is available as creams, lozenges, and vaginal suppositories.

Berat Molekul

344,8000 g/mol

LogP

5,00

TPSA

17,80 Ų

Lipinski RO5

Lulus

Area Terapeutik

Mekanisme Kerja

Inhibits the fungal cytochrome P450 enzyme lanosterol 14-alpha-demethylase, blocking ergosterol synthesis essential for fungal cell membrane integrity.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanisme

Inhibits the fungal cytochrome P450 enzyme lanosterol 14-alpha-demethylase, blocking ergosterol synthesis essential for fungal cell membrane integrity.

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1

InChI

InChI=1S/C22H17ClN2/c23-21-14-8-7-13-20(21)22(25-16-15-24-17-25,18-9-3-1-4-10-18)19-11-5-2-6-12-19/h1-17H

Molecular Formula

C22H17ClN2

HBD / HBA

- / 1

Ikatan yang Dapat Dirotasi

4

Atom Berat

25

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

A broad-spectrum azole antifungal that disrupts fungal cell membranes by inhibiting ergosterol synthesis, used to treat athlete's foot, vaginal yeast infections, and oral thrush. It is available as creams, lozenges, and vaginal suppositories.

Inhibits the fungal cytochrome P450 enzyme lanosterol 14-alpha-demethylase, blocking ergosterol synthesis essential for fungal cell membrane integrity.

Yes, Clotrimazole is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL104. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 2812. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.